Lesions by tissue specific imaging characterize multiple sclerosis patients with more advanced disease

Multiple Sclerosis Journal

Volumn 17, Issue 12, 2011, Pages 1424-1431

  Bagnato, Francesca ^a   Ikonomidou, Vasiliki N ^b   Van Gelderen, Peter ^a   Auh, Sungyoung ^a   Hanafy, Jailan ^a   Cantor, Fredric K ^a   Ohayon, Joan ^a   Richert, Nancy ^a   Duyn, Jeff ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b Krasnow Institute for Advanced Study   (United States)

Author keywords

atrophy; Axonal loss; demyelination; MRI; Multiple sclerosis; T2 lesions

Indexed keywords

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DISABILITY; DISEASE DURATION; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING;

EID: 82555194253     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511414601     Document Type: Article

References (30)

1. van Walderveen MAA, Truyen L, van Oosten BW, et al. Development of hypointense lesions on T1-weighted spin-echo magnetic resonance images in multiple sclerosis lesions: relation to inflammatory activity. Arch Neurol. 1999 ; 56: 345-351 (Pubitemid 29120233)
2. Ciccarelli O, Giugni E, Paolillo A, et al. Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosis. Eur J Neurol. 1999 ; 6: 455-459 (Pubitemid 29371143)
3. Filippi M, Rovaris M, Rocca MA, et al. Glatimerar acetate reduces the proportion of new MS lesions evolving into "black holes". Neurology. 2001 ; 57: 731-733 (Pubitemid 32783013)
4. Brex PA, Molyneux PD, Smiddy P, et al. The effect of IFNbeta-1b on the evolution of enhancing lesions in secondary progressive MS. Neurology. 2001 ; 57: 2185-2190 (Pubitemid 34016449)
5. Bagnato F, Jeffries N, Richert N, et al. Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years. Brain. 2003 ; 126: 1782-1789 (Pubitemid 36917337)
6. Freitag P, Mueller B, Radue EW, et al. Individual changes of chronic black holes. Mult Scler. 2001 ; 7 (S1). P094
7. Sailer M, Losseff NA, Wang L, et al. T1 lesion load and cerebral atrophy as a marker for clinical progression in patients with multiple sclerosis: a prospective 18 months follow-up study. Eur J Neurol. 2001 ; 8: 37-42 (Pubitemid 32154572)
8. Truyen L, van Waesberghe JH, van Walderveen MA, et al. Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology. 1996 ; 47: 1469-1476 (Pubitemid 26422538)
9. van Walderveen MAA, Kamphorst W, Scheltens P, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology. 1998 ; 50: 1282-1288 (Pubitemid 28240340)
10. Bruck W, Bitsch A, Kolenda H, et al. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol. 1997 ; 42: 783-793 (Pubitemid 27481551)
11. van Waesberghe JHTM, Kamphorst W, De Groot CJA, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol. 1999 ; 46: 747-754 (Pubitemid 29518136)
12. Bitsch A, Kuhlmann T, Stadelmann C, et al. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol. 2001 ; 49: 793-796 (Pubitemid 32530247)
13. Barkhof F, Bruck W, De Groot CJ, et al. Remyelinated lesions in multiple sclerosis. Magnetic resonance image appearance. Arch Neurol. 2003 ; 60: 1073-1081 (Pubitemid 36975794)
14. Lassmann H. The pathological substrate of magnetic resonance alterations in multiple sclerosis. Neuroimag Clin N Am. 2008 ; 18: 563-576
15. Ikonomidou VN, van Gelderen P, de Zwart JA, et al. Optimizing brain tissue contrast with EPI: a simulated annealing approach. Magn Res Med. 2005 ; 54: 373-385 (Pubitemid 41033554)
16. Riva M, Ikonomidou V, Ostuni JJ, et al. Tissue-specific imaging is a robust methodology to differentiate in vivo t1 black holes with advanced multiple sclerosis-induced damage. AJNR Am J Neuroradiol. 2009 ; 30: 1394-1401
17. Bottomley PA, Foster TH, Argensinger RE, et al. A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1-100 MHz: dependence on tissue type, NMR frequency, temperature, species, excision and age. Med Phys. 1984 ; 11: 425-448 (Pubitemid 14057394)
18. Bagnato F, Frank JA. The role of nonconventional magnetic resonance imaging techniques in demyelinating disorders. Curr Neurol Neurosci Rep. 2003 ; 3: 238-245 (Pubitemid 38899008)
19. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 ; 13: 227-231 (Pubitemid 13158528)
20. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 ; 33: 1444-1452 (Pubitemid 14237132)
21. Collins DL, Neelin P, Peters TM, Evans AC. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr. 1994 ; 18: 192-205 (Pubitemid 24100002)
22. Bagnato F, Butman JA, Mora CA, et al. Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis. J Neurovirol. 2005 ; 11: 525-534 (Pubitemid 43123771)
23. Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. NeuroImage. 2002 ; 17: 479-489
24. Horská A, Calhoun VD, Bradshaw DH, Barker PB. Rapid method for correction of CSF partial volume in quantitative proton MR spectroscopic imaging. Magn Reson Med. 2002 ; 48: 555-558 (Pubitemid 34951338)
25. Skinner MG, Kolind SH, MacKay AL. The effect of varying echo spacing within a multiecho acquisition: better characterization of long T2 components. Magn Reson Imag. 2007 ; 25: 840-847 (Pubitemid 47081361)
26. Barkhof F, Karas GB, Van Walderveen MA. T1 hypointensities and axonal loss. Neuroimag Clin N Am. 2000 ; 10: 739-752 (Pubitemid 32391265)
27. Bagnato F, Evangelou I, Gaindh D, Gallo A, Yao K. The role of interferon beta in T1-hypointense black holes in multiple sclerosis. Exp Opin Biol Ther. 2007 ; 7: 1079-1091 (Pubitemid 47204360)
28. Sahraian MA, Radue EW, Haller S, Kappos L. Black holes in multiple sclerosis: definition evolution and clinical correlations. Acta Neurol Scand. 2009 ; 122: 1-8
29. Sicotte NL, Voskuhl RR, Bouvier S, Klutch R, Cohen MS, Mazziotta JC. Comparisons of multiple sclerosis lesions at 1.5 and 3.0 Tesla. Invest Radiol. 2003 ; 38: 423-427 (Pubitemid 36791336)
30. Stankiewicz JM, Glanz BI, Healy BC, et al. Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis. J Neuroimag. 2011 ; 21: e50 - e56